Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ad free!Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ad free today!Spring offer! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Novartis
Pharmaceuticals
AstraZeneca
Pfizer
GSK
Novo Nordisk
Johnson and Johnson
Roche
Sanofi
Eli Lilly
Zoetis
Topics

Advertisement

Novartis

Share

Top Latest Popular

🗞️ NEWSNOW ESSENTIALS | Support independent news discovery ad free at just £2.99/m!

🗞️ NEWSNOW ESSENTIALS | Support independent news discovery ad free at just £2.99 a month!

Novartis reports positive results from Phase III ALIGN trial for IgAN Clinical Trials Arena 4d

Clinical Trials Arena 4d

Vanrafia The Lancet

ASCO 2026: Mixed Sclc result for Legend’s LB2102, Novartis expedites manufacture Pharmaceutical Technology 7d

Pharmaceutical Technology 7d

Biotech Cancer Treatment

Novartis Cosentyx shows sustained remission in polymyalgia rheumatica RTT News 5d

RTT News 5d

Cosentyx Biotech

Advertisement

Advertisement

Advertisement

Latest

Yesterday

Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026 Novartis (Press Release) 08:53 Mon, 08 Jun

Friday

Novartis reports positive results from Phase III ALIGN trial for IgAN Clinical Trials Arena 10:44 Fri, 05 Jun

EULAR: Novartis Closes In On Final Approval For Cosentyx Scrip Pharma Intelligence 08:23 Fri, 05 Jun

Thursday

Novartis Vanrafia Data Show Clinically Meaningful Kidney Protection In IgA Nephropathy RTT News 12:51 Thu, 04 Jun

Novartis IgAN data in The Lancet show clinically meaningful slowing of kidney function decline with Vanrafia® over 2.5 years Novartis (Press Release) 11:29 Thu, 04 Jun

Novartis Cosentyx Shows Sustained Remission In Polymyalgia Rheumatica RTT News 10:49 Thu, 04 Jun

Wednesday

Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients Novartis (Press Release) 16:38 Wed, 03 Jun

In the last month

Accelerating Structure Verification Across Novartis Drugs Discovery Online 19:37 Tue, 02 Jun

ASCO 2026: Mixed SCLC result for Legend’s LB2102, Novartis expedites manufacture Pharmaceutical Technology 17:13 Tue, 02 Jun

Novartis Pluvicto And Actinium Program Advance Radioligand Therapy In Prostate Cancer RTT News 09:46 Mon, 01 Jun

Advertisement

Advertisement

Advertisement

About our Novartis news

Latest news for Novartis, a global healthcare company based in Switzerland specialising in pharmaceuticals, including updates on company and product news.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Industry Sectors Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Shire Shire
- Takeda Takeda
- Teva Teva
- Valneva Valneva
- Zoetis Zoetis